Mexico extols epilepsy diagnosis and surgery:
This article was originally published in Clinica
Executive Summary
Mexico is advocating greater use of surgery for the treatment of epilepsy. The technique reduces the intensity of epilepsy attacks by up to 80% in patients who do not respond to pharmaceutical treatment, says the health ministry, citing Rodolfo Ondarza Rovira, of the national neurology and neurosurgery institute (INNN). There is, however, a pressing need to encourage earlier diagnosis and a greater willingness to undergo surgery, through an information campaign that highlights its little-known potential, claims Dr Ondarza. Epilepsy affects around 120 per 100,000 population, and ranks among the most common conditions treated at the INNN - some 700 cases a month.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.